Literature DB >> 4235691

Synthesis and intracellular localization of vaccinia virus deoxyribonucleic acid-dependent ribonucleic acid polymerase.

J Kates, R Dahl, M Mielke.   

Abstract

The time course of vaccinia deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase synthesis and its intracellular localization were studied with virus-infected HeLa cells. Viral RNA polymerase activity could be meassured shortly after viral infection in the cytoplasmic fraction of infected cells in vitro. However, unless the cells were broken in the presence of the nonionic detergent Triton-X-100, no significant synthesis of new RNA polymerase was detected during the viral growth cycle. When cells were broken in the presence of this detergent, extensive increases in viral RNA polymerase activity were observed late in the infection cycle. The onset of new RNA polymerase synthesis was dependent on prior viral DNA replication. Fluorodeoxyuridine (5 x 10(-5)m) prevented the onset of viral polymerase synthesis. Streptovitacin A, a specific and complete inhibitor of protein synthesis in HeLa cells, prevented the synthesis of RNA polymerase. Thus, the synthesis of RNA polymerase is a "late" function of the virus. The newly synthesized RNA polymerase activity was primarily bound to particles which sedimented during high-speed centrifugation. These particles have been characterized by sucrose gradient centrifugation. A major class of active RNA polymerase particles were considerably "lighter" than whole virus in sucrose gradients. These particles were entirely resistant to the action of added pancreatic deoxyribonuclease, and they were not stimulated by added calf thymus primer DNA. It is concluded that these particles are not active in RNA synthesis in vivo, and that activation occurs as a result of detergent treatment in vitro.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4235691      PMCID: PMC375709     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  THE REPLICATION AND COATING OF VACCINIA DNA.

Authors:  W K JOKLIK; Y BECKER
Journal:  J Mol Biol       Date:  1964-12       Impact factor: 5.469

2.  The initiation of vaccinia infection.

Authors:  J CAIRNS
Journal:  Virology       Date:  1960-07       Impact factor: 3.616

3.  The preparation and characteristics of highly purified radioactively labelled poxvirus.

Authors:  W K JOKLIK
Journal:  Biochim Biophys Acta       Date:  1962-08-20

4.  Messenger RNA synthesis by a "coated" viral genome.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

5.  Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA.

Authors:  K I Oda; W K Joklik
Journal:  J Mol Biol       Date:  1967-08-14       Impact factor: 5.469

6.  Regulation of virus-induced deoxyribonucleases.

Authors:  B R McAuslan; J R Kates
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

7.  Relationship between protein synthesis and viral deoxyribonucleic acid synthesis.

Authors:  J R Kates; B R McAuslan
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

8.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

9.  In vitro synthesis of T4 late messenger RNA.

Authors:  L Snyder; E P Geiduschek
Journal:  Proc Natl Acad Sci U S A       Date:  1968-02       Impact factor: 11.205

10.  The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid.

Authors:  S DALES
Journal:  J Cell Biol       Date:  1963-07       Impact factor: 10.539

  10 in total
  9 in total

Review 1.  Amanitins in virus research.

Authors:  G Campadelli-Fiume
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Failure of rifampin to inhibit frog polyhedral cytoplasmic deoxyribovirus multiplication.

Authors:  L S Kucera
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

3.  Ribonucleic acid polymerase induced by vaccinia virus: lack of inhibition by rifampicin and alpha-amanitin.

Authors:  F Costanzo; L Fiume; M La Placa; A Mannini-Palenzona; F Novello; F Stirpe
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

4.  Regulation of the synthesis of nucleotide phosphohydrolase and neutral deoxyribonuclease: two activities present within purified vaccina virus.

Authors:  B G Pogo; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

5.  Phenotypic characterization of temperature-sensitive mutants of vaccinia virus with mutations in a 135,000-Mr subunit of the virion-associated DNA-dependent RNA polymerase.

Authors:  M J Ensinger
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

7.  Synthesis of polynucleotide 5'-triphosphatase in vaccinia virus-infected HeLa cells.

Authors:  D J Tutas; E Paoletti
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Poly(A) polymerase from vaccinia virus-infected cells. I. Partial purification and characterization.

Authors:  C Brakel; J R Kates
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

9.  Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.

Authors:  E Katz; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.